Investor Info

Investor Information

Founded in Australia in 2016, Medcan Australia was one of Australia’s first licenced cultivation companies and is a wholly owned subsidiary of the Medcan Group.

Since 2016 Medcan has aggressively yet systematically executed on its business model. As a vertical integrated business with successful operations throughout the supply pathway, Medcan is an Industry leader.

Medcan operates as a profitable business and was the first Australian Medicinal Cannabis company to pay a shareholder dividend in 2021. Since then Medcan has paid regular shareholder dividends and continues to position itself as a significant, credible industry leader as its operations expand.

To find out more about our expansion plans, please contact us by email for further information at

Please note, the information contained on this webpage does not constitute an offer or invitation to subscribe for shares, however any implied offer herein is an excluded offer pursuant to Sections 708(8) and (11) of the Corporations Act 2001 (Cth).

This field is for validation purposes and should be left unchanged.


Medical Cannabis


Medical Cannabis


Advanced Treatments